Title: Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Record: SENGUPTA, Amitabha - KABÁT, Juraj - NOVÁK, Michal - WU, Qiongli - GRUNDKE-IQBAL, Inge - IQBAL, Khalid. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. In: Archives of Biochemistry and Biophysics. 1998. ISSN 0003-9861, Vol. 357, č. 2(1998), s. 299-309.
(1998: 2.497 - IF)
Year: 1998
Category: ADC - Scientific papers in foreign journals
Authors:SENGUPTA Amitabha0 %
KABÁT Juraj0 %
NOVÁK Michal0 %
WU Qiongli0 %
GRUNDKE-IQBAL Inge0 %
IQBAL Khalid0 %
Edition: Archives of Biochemistry and Biophysics
Vol. 357, č. 2(1998), s. 299-309
Country of issue: Slovakia
ISSN:0003-9861
Research area: neuvedená
Scientometrics: 1998: 2.497 - IF
Language: english
Citations:
2013: [1] HASHIGUCHI, M. - HASHIGUCHI, T. Kinase-Kinase Interaction and Modulation of Tau Phosphorylation. In International Review of Cell and Molecular Biology, 2013, vol.300, 121-160. [Scopus]
2013: [1] KILLICK, R. - HUGHES, T.R. - MORGAN, B.P. - LOVESTONE, S. Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. In Neuroscience Letters, 2013, vol.533, no.1, 96-99. [Scopus]
2013: [1] MARTIN, L. - LATYPOVA, X. - WILSON, C.M. - MAGNAUDEIX, A. - PERRIN, M.-L. - YARDIN, C. - TERRO, F. Tau protein kinases: Involvement in Alzheimer's disease. In Ageing Research Reviews, 2013, vol.12, no.1, 289-309. [Scopus]
2012: [1] CATALGOL, B. - GRUNE, T. Proteasome and neurodegenerative diseases. In Progress in Molecular Biology and Translational Science, 2012, vol.109, 397-414. [Scopus]
2012: [1] CUI, B. - ZHU, L. - SHE, X. - WU, M. - MA, Q. - WANG, T. - ZHANG, N. - XU, C. - CHEN, X. - AN, G. - LIU, H. Chronic noise exposure causes persistence of tau hyperphosphorylation and formation of NFT tau in the rat hippocampus and prefrontal cortex. In Experimental Neurology, 2012, vol.238, no.2, 122-129. [Scopus]
2012: [1] DONG, Y. - WU, X. - XU, Z. - ZHANG, Y. - XIE, Z. Anesthetic isoflurane increases phosphorylated tau levels mediated by caspase activation and Aβ generation. In PLoS ONE, 2012, vol.7, no.6. [Scopus]
2012: [1] GILLEY, J. - SEEREERAM, A. - ANDO, K. - MOSELY, S. - ANDREWS, S. - KERSCHENSTEINER, M. - MISGELD, T. - BRION, J.-P. - ANDERTON, B. - HANGER, D.P. - COLEMAN, M.P. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. In Neurobiology of Aging, 2012, vol.33, no.3, 621.e1-621.e15. [Scopus]
2012: [1] LASAGNA-REEVES, C.A. - CASTILLO-CARRANZA, D.L. - SENGUPTA, U. - SARMIENTO, J. - TRONCOSO, J. - JACKSON, G.R. - KAYED, R. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. In FASEB Journal, 2012, vol.26, no.5, 1946-1959. [Scopus]
2012: [1] LÉNÁRT, N. - SZEGEDI, V. - JUHÁSZ, G. - KASZTNER, A. - HORVÁTH, J. - BERECZKI, E. - TÓTH, M.E. - PENKE, B. - SÁNTHA, M. Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice. In PLoS ONE, 2012, vol.7, no.9. [Scopus]
2012: [1] MEDEIROS, R. - KITAZAWA, M. - CHABRIER, M.A. - CHENG, D. - BAGLIETTO-VARGAS, D. - KLING, A. - MOELLER, A. - GREEN, K.N. - LAFERLA, F.M. Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice. In American Journal of Pathology, 2012, vol.181, no.2, 616-625. [Scopus]
2012: [1] WEI, Y. - MIAO, J.-Y. - LIU, Y. Endogenous and exogenous factors in hyperphosphorylation of tau in Alzheimer's disease. In Progress in Biochemistry and Biophysics, 2012, vol.39, no.8, 778-784. [Scopus]
2012: [1] WHEELER, J.M. - GUTHRIE, C.R. - KRAEMER, B.C. Potential neuroprotective strategies against tauopathy. In Biochemical Society Transactions, 2012, vol.40, no.4, 656-660. [Scopus]
2012: [1] ZAHID, S. - OELLERICH, M. - ASIF, A. - AHMED, N. Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. In Journal of Neurochemistry, 2012, vol.121, no.6, 954-963. [Scopus]
2012: [1] ZHOU, F. - CHEN, S. - XIONG, J. - LI, Y. - QU, L. Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells. In Biological Trace Element Research, 2012, vol.149, no.2, 273-279. [Scopus]
2011: [1] AMADORO, G. - CORSETTI, V. - CIOTTI, M.T. - FLORENZANO, F. - CAPSONI, S. - AMATO, G. - CALISSANO, P. Endogenous Aβ causes cell death via early tau hyperphosphorylation. In Neurobiology of Aging, 2011, vol.32, no.6, 969-990. [Scopus]
2011: [1] DAIRE, V. - POÜS, C. Kinesins and protein kinases: Key players in the regulation of microtubule dynamics and organization. In Archives of Biochemistry and Biophysics, 2011, vol.510, no.2, 83-92. [Scopus]
2011: [1] HAGGERTY, T. - CREDLE, J. - RODRIGUEZ, O. - WILLS, J. - OAKS, A.W. - MASLIAH, E. - SIDHU, A. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. In European Journal of Neuroscience, 2011, vol.33, no.9, 1598-1610. [Scopus]
2011: [1] LEE, S. - HALL, G.F. - SHEA, T.B. Potentiation of tau aggregation by cdk5 and GSK3β. In Journal of Alzheimer's Disease, 2011, vol.26, no.2, 355-364. [Scopus]
2011: [1] MARCUS, J.N. - SCHACHTER, J. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease. In Journal of Neurogenetics, 2011, vol.25, no.4, 127-133. [Scopus]
2011: [1] MARTIN, L. - LATYPOVA, X. - TERRO, F. Post-translational modifications of tau protein: Implications for Alzheimer's disease. In Neurochemistry International, 2011, vol.58, no.4, 458-471. [Scopus]
2011: [1] MARTIN, L. - MAGNAUDEIX, A. - WILSON, C.M. - YARDIN, C. - TERRO, F. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons. In Journal of Neuroscience Research, 2011, vol.89, no.11, 1802-1811. [Scopus]
2011: [1] MEDEIROS, R. - BAGLIETTO-VARGAS, D. - LAFERLA, F.M. The Role of Tau in Alzheimer's Disease and Related Disorders. In CNS Neuroscience and Therapeutics, 2011, vol.17, no.5, 514-524. [Scopus]
2011: [1] OBULESU, M. - VENU, R. - SOMASHEKHAR, R. Tau mediated neurodegeneration: An insight into Alzheimer's disease pathology. In Neurochemical Research, 2011, vol.36, no.8, 1329-1335. [Scopus]
2011: [1] OSIECKA, K.M. - NIEZNANSKA, H. - SKOWRONEK, K.J. - JOZWIAK, J. - NIEZNANSKI, K. Tau inhibits tubulin oligomerization induced by prion protein. In Biochimica et Biophysica Acta Molecular Cell Research, 2011, vol.1813, no.10, 1845-1853. [Scopus]
2011: [1] RAY, B. - REYES, P.F. - LAHIRI, D.K. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau. In Journal of Psychiatric Research, 2011, vol.45, no.4, 539-547. [Scopus]
2011: [1] RUDRABHATLA, P. - JAFFE, H. - PANT, H.C. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): Phosphoproteomics of Alzheimer's NFTs. In FASEB Journal, 2011, vol.25, no.11, 3896-3905. [Scopus]
2011: [1] SOTIROPOULOS, I. - CATANIA, C. - PINTO, L.G. - SILVA, R. - POLLERBERG, G.E. - TAKASHIMA, A. - SOUSA, N. - ALMEIDA, O.F.X. Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. In Journal of Neuroscience, 2011, vol.31, no.21, 7840-7847. [Scopus]
2011: [1] WILLS, J. - CREDLE, J. - HAGGERTY, T. - LEE, J.-H. - OAKS, A.W. - SIDHU, A. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. In PLoS ONE, 2011, vol.6, no.3. [Scopus]
2011: [1] YUZWA, S.A. - YADAV, A.K. - SKOROBOGATKO, Y. - CLARK, T. - VOSSELLER, K. - VOCADLO, D.J. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. In Amino Acids, 2011, vol.40, no.3, 857-868. [Scopus]
Skip to content